AGARWALEYE Dr. Agarwal's Health Care Q1 FY27 results (Apr–Jun 2026) and concall
Dr. Agarwal's Health Care Limited delivered a strong Q1 FY27, marked by robust revenue and EBITDA growth, significant margin expansion, and record-breaking network expansion with 18 new facilities. The company saw strong performance across all regions, driven by increased patient volumes and a focus on high-end surgical procedures. Management remains confident in its full-year expansion plans and expects continued growth in realization and operational efficiency.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 26.8%, net profit up 70.0% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 255 | 268 | 281 | 302 | 309 +21% | 335 +25% | 348 +24% | 383 +27% |
| EBITDA | 58 | 65 | 73 | 67 | 69 +19% | 80 +23% | 92 +26% | 96 +43% |
| Net profit | -4 | 8 | 27 | 10 | 5 +225% | 14 +75% | 11 −59% | 17 +70% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
